Novel and emerging physical treatments for major depressive disorder

Major depressive disorder (MDD), a widespread psychiatric disease with significant impacts on neurological functioning and quality of life, affects 4.4% of the global population. Despite the availability of various treatments, including antidepressants and cognitive behavioral therapy, approximately 50% of patients with MDD exhibit inadequate responses, leading to treatment-resistant depression (TRD). This review evaluates novel physical treatments for depression, focusing on music therapy, light therapy, cold therapy, and brain stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), and deep-brain stimulation (DBS). Music therapy leverages the emotional and social benefits of music to improve mood and cognitive function. Light therapy influences circadian rhythms and neurotransmitter modulation to reduce depressive symptoms. Cold therapy, by regulating the hypothalamic-pituitary-adrenal (HPA) axis and neurotransmitter systems, offers a promising approach for depression management. Brain stimulation techniques, including rTMS, tDCS, and DBS, provide non-pharmacological alternatives by modulating brain activity and connectivity. Although these novel treatments show potential, significant variabilities in clinical outcomes highlight the need for personalized treatment strategies. Future research should prioritize elucidating the mechanisms of these therapies, optimizing treatment protocols, and conducting larger randomized controlled trials to evaluate their efficacy and safety. The integration of advanced technologies and comprehensive mechanistic analyses will be crucial for advancing the field and improving treatment outcomes for MDD.